Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney Cancer Therapeutics and Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney Cancer Therapeutics and Diagnosticsmarket, defines the market attractiveness level of Kidney Cancer Therapeutics and Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney Cancer Therapeutics and Diagnostics industry, describes the types of Kidney Cancer Therapeutics and Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney Cancer Therapeutics and Diagnostics market and the development prospects and opportunities of Kidney Cancer Therapeutics and Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney Cancer Therapeutics and Diagnostics market in Chapter 13.
By Player:
Hoffmann La Roche
Genentech
Abbott Laboratories
Cerulean Pharma
Pfizer
Novartis
Amgen
Seattle Genetics
GlaxoSmithKline
By Type:
Cystoscopy
Biopsy
Intravenous Pyelogram
CT Scan
Kidney Ultrasound
Others
By End-User:
Hospitals
Pharmaceutical Labs
Genomics Laboratories
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney Cancer Therapeutics and Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney Cancer Therapeutics and Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney Cancer Therapeutics and Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney Cancer Therapeutics and Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney Cancer Therapeutics and Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.2 United States Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.3 Europe Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.4 China Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.5 Japan Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.6 India Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
-
7.7 South Korea Kidney Cancer Therapeutics and Diagnostics Consumption (2017-2022)
8 Region and Country-wise Kidney Cancer Therapeutics and Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney Cancer Therapeutics and Diagnostics Consumption Forecast (2022-2028)
9 Global Kidney Cancer Therapeutics and Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cystoscopy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Biopsy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Intravenous Pyelogram Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CT Scan Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Kidney Ultrasound Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Labs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Genomics Laboratories Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Kidney Cancer Therapeutics and Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cystoscopy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Intravenous Pyelogram Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CT Scan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Kidney Ultrasound Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Labs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Genomics Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney Cancer Therapeutics and Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney Cancer Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney Cancer Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney Cancer Therapeutics and Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney Cancer Therapeutics and Diagnostics Market Competitive Analysis
-
14.1 Hoffmann La Roche
-
14.1.1 Hoffmann La Roche Company Details
-
14.1.2 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.2 Genentech
-
14.2.1 Genentech Company Details
-
14.2.2 Genentech Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genentech Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.4 Cerulean Pharma
-
14.4.1 Cerulean Pharma Company Details
-
14.4.2 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.7 Amgen
-
14.7.1 Amgen Company Details
-
14.7.2 Amgen Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.8 Seattle Genetics
-
14.8.1 Seattle Genetics Company Details
-
14.8.2 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product and Service
-
14.9 GlaxoSmithKline
-
14.9.1 GlaxoSmithKline Company Details
-
14.9.2 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney Cancer Therapeutics and Diagnostics
-
Figure Kidney Cancer Therapeutics and Diagnostics Picture
-
Table Global Kidney Cancer Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Cancer Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Cancer Therapeutics and Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney Cancer Therapeutics and Diagnostics Consumption by Country (2017-2022)
-
Figure United States Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Cancer Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Therapeutics and Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Cancer Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cystoscopy Consumption and Growth Rate (2017-2022)
-
Figure Global Biopsy Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Pyelogram Consumption and Growth Rate (2017-2022)
-
Figure Global CT Scan Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Ultrasound Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Labs Consumption and Growth Rate (2017-2022)
-
Figure Global Genomics Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cystoscopy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Pyelogram Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CT Scan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Ultrasound Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Labs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genomics Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney Cancer Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney Cancer Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Hoffmann La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Cerulean Pharma (Foundation Year, Company Profile and etc.)
-
Table Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product and Service
-
